Devicemakers Planning To Cut Back on R&D to Pay for Excise Tax

Devices & Diagnostics Letter
Nearly half of devicemakers (44 percent) in a recent survey said they would pass the costs of the new medical device excise tax on to their customers.

To View This Article:


Subscribe To Devices & Diagnostics Letter

Buy This Article Now

Add this article to your cart for $25.00